Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Hsu, Wei Chun ^a,b   Nenov, Miroslav N ^a   Shavkunov, Alexander ^a   Panova, Neli ^a   Zhan, Ming ^c   Laezza, Fernanda ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; FIBROBLAST GROWTH FACTOR 14; GLYCOGEN SYNTHASE KINASE 3; LUCIFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; SODIUM CHANNEL NAV1.6; UNCLASSIFIED DRUG; WEE1 KINASE; FIBROBLAST GROWTH FACTOR; PROTEIN KINASE INHIBITOR; SCN8A PROTEIN, HUMAN; SCN8A PROTEIN, RAT;

ARTICLE; BIOLUMINESCENCE; BIOLUMINESCENCE BASED LUCIFERASE COMPLEMENTATION ASSAY; CELL CULTURE; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; HIPPOCAMPUS; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; NERVE CELL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; VALIDATION STUDY; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; GENETIC COMPLEMENTATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; PROCEDURES; RAT; SIGNAL TRANSDUCTION;

ANIMALS; FIBROBLAST GROWTH FACTORS; GENETIC COMPLEMENTATION TEST; HEK293 CELLS; HIPPOCAMPUS; HUMANS; LUCIFERASES; NAV1.6 VOLTAGE-GATED SODIUM CHANNEL; NEURONS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION;

EID: 84922572433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117246     Document Type: Article

References (75)

1. Kramer T, Lo Monte F, Goring S, Okala Amombo GM, Schmidt B (2012) Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models. ACS Chem Neurosci 3: 151-160. doi: 10.1021/cn200117j PMID: 22860184
2. Smith B, Medda F, Gokhale V, Dunckley T, Hulme C (2012) Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's? ACS Chem Neurosci 3: 857-872. doi: 10.1021/cn300094k PMID: 23173067
3. Malhi GS, Tanious M, Das P, Coulston CM, Berk M (2013) Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs 27: 135-153. doi: 10.1007/s40263-013-0039-0 PMID: 23371914
4. Chiu CT, Chuang DM (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128: 281-304. doi: 10.1016/j.pharmthera.2010.07. 006 PMID: 20705090
5. Jope RS, Roh MS (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7: 1421-1434. PMID: 17100582
6. Li X, Frye MA, Shelton RC (2012) Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology 37: 77-101. doi: 10.1038/npp.2011.198 PMID: 21900884
7. Hsu WC, Nilsson CL, Laezza F (2014) Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and intervention. Front Psychiatry 5: 109. doi: 10.3389/fpsyt.2014.00109 PMID: 25191280
8. Lorincz A, Nusser Z (2010) Molecular identity of dendritic voltage-gated sodium channels. Science 328: 906-909. doi: 10.1126/science.1187958 PMID: 20466935
9. Clay JR (2005) Axonal excitability revisited. Prog Biophys Mol Biol 88: 59-90. PMID: 15561301
10. Yu FH, Catterall WA (2003) Overview of the voltage-gated sodium channel family. Genome Biol 4: 207. PMID: 12620097
11. Cantrell AR, Catterall WA (2001) Neuromodulation of Na+ channels: an unexpected form of cellular plasticity. Nat Rev Neurosci 2: 397-407. PMID: 11389473
12. Buffington SA, Rasband MN (2011) The axon initial segment in nervous system disease and injury. Eur J Neurosci 34: 1609-1619. doi: 10.1111/j.1460-9568.2011.07875.x PMID: 22103418
13. Hsu W-CJ, Nilsson CL, Laezza F (2014) The role of the axonal initial segment in psychiatric disorders: function, dysfunction, and intervention. Frontiers in Psychiatry 5.
14. Laezza F, Gerber BR, Lou JY, Kozel MA, Hartman H, et al. (2007) The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability. J Neurosci 27: 12033-12044. PMID: 17978045
15. Laezza F, Lampert A, Kozel MA, Gerber BR, Rush AM, et al. (2009) FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci 42: 90-101. doi: 10.1016/j.mcn.2009.05.007 PMID: 19465131
16. Lou JY, Laezza F, Gerber BR, Xiao M, Yamada KA, et al. (2005) Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol 569: 179-193. PMID: 16166153
17. Wang Q, McEwen DG, Ornitz DM (2000) Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14. Mech Dev 90: 283-287. PMID: 10640713
18. Wang Q, Bardgett ME, Wong M, Wozniak DF, Lou J, et al. (2002) Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron 35: 25-38. PMID: 12123606
19. Xiao M, Xu L, Laezza F, Yamada K, Feng S, et al. (2007) Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14. Mol Cell Neurosci 34: 366-377. PMID: 17208450
20. Goetz R, Dover K, Laezza F, Shtraizent N, Huang X, et al. (2009) Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem 284: 17883-17896. doi: 10.1074/jbc.M109.001842 PMID: 19406745
21. Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, et al. (2006) Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype. Mov Disord 21: 396-401. PMID: 16211615
22. Wozniak DF, Xiao M, Xu L, Yamada KA, Ornitz DM (2007) Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14. Neurobiol Dis 26: 14-26. PMID: 17236779
23. Verbeek EC, Bakker IM, Bevova MR, Bochdanovits Z, Rizzu P, et al. (2012) A fine-mapping study of 7 top scoring genes from a GWAS for major depressive disorder. PLoS One 7: e37384. doi: 10.1371/journal.pone.0037384 PMID: 22649524
24. Rodriguez-Murillo L, Xu B, Roos JL, Abecasis GR, Gogos JA, et al. (2014) Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia. Neuropsychopharmacology 39: 934-943. doi: 10.1038/npp.2013.293 PMID: 24141571
25. Shavkunov AS, Wildburger NC, Nenov MN, James TF, Buzhdygan TP, et al. (2013) The Fibroblast Growth Factor 14/Voltage-gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3). J Biol Chem 288: 19370-19385. doi: 10.1074/jbc.M112.445924 PMID: 23640885
26. Shavkunov A, Panova N, Prasai A, Veselenak R, Bourne N, et al. (2012) Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex. Assay Drug Dev Technol 10: 148-160. doi: 10.1089/adt.2011.413 PMID: 22364545
27. Michnick SW, Ear PH, Landry C, Malleshaiah MK, Messier V (2011) Protein-fragment complementation assays for large-scale analysis, functional dissection and dynamic studies of protein-protein interactions in living cells. Methods Mol Biol 756: 395-425. doi: 10.1007/978-1-61779-160-4-25 PMID: 21870242
28. Luker KE, Smith MC, Luker GD, Gammon ST, Piwnica-Worms H, et al. (2004) Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci U S A 101: 12288-12293. PMID: 15284440
29. Dar AC, Shokat KM (2011) The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Annu Rev Biochem 80: 769-795. doi: 10.1146/annurev-biochem-090308-173656 PMID: 21548788
30. Stephenson RP (1997) A modification of receptor theory. 1956. Br J Pharmacol 120: 106-120; discussion 103-105. PMID: 9142399
31. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29: 1039-1045. doi: 10.1038/nbt.2017 PMID: 22037377
32. Fedorov O, Marsden B, Pogacic V, Rellos P, Muller S, et al. (2007) A systematic interactionmap of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A 104: 20523-20528. PMID: 18077363
33. Miah SM, Sada K, Tuazon PT, Ling J, Maeno K, et al. (2004) Activation of Syk protein tyrosine kinase in response to osmotic stress requires interaction with p21-activated protein kinase Pak2/gamma-PAK. Mol Cell Biol 24: 71-83. PMID: 14673144
34. Jacinto E, Werlen G, Karin M (1998) Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity 8: 31-41. PMID: 9462509
35. Muller M, Lutter D, Puschel AW (2010) Persistence of the cell-cycle checkpoint kinase Wee1 in SadAand SadB-deficient neurons disrupts neuronal polarity. J Cell Sci. England. pp. 286-294.
36. Berendt FJ, Park KS, Trimmer JS (2010)Multisite phosphorylation of voltage-gated sodium channel alpha subunits from rat brain. J Proteome Res 9: 1976-1984. doi: 10.1021/pr901171q PMID: 20131913
37. Scheuer T (2011) Regulation of sodium channel activity by phosphorylation. Semin Cell Dev Biol 22: 160-165. doi: 10.1016/j.semcdb.2010.10.002 PMID: 20950703
38. Wittmack EK, Rush AM, Hudmon A, Waxman SG, Dib-Hajj SD (2005) Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-activated protein kinase. J Neurosci 25: 6621-6630. PMID: 16014723
39. Tomashevski A, Husseman J, Jin LW, Nochlin D, Vincent I (2001) Constitutive Wee1 activity in adult brain neurons with M phase-type alterations in Alzheimer neurodegeneration. J Alzheimers Dis 3: 195-207. PMID: 12214061
40. Watanabe N, Arai H, Nishihara Y, Taniguchi M, Hunter T, et al. (2004) M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc Natl Acad Sci U S A 101: 4419-4424. PMID: 15070733
41. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, et al. (2012) Wnt signaling through inhibition of β- catenin degradation in an intact Axin1 complex. Cell 149: 1245-1256. doi: 10.1016/j.cell.2012.05.002 PMID: 22682247
42. Cen L, Carlson BL, Schroeder MA, Ostrem JL, Kitange GJ, et al. (2012) p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells. Neuro Oncol 14: 870-881. doi: 10.1093/neuonc/nos114 PMID: 22711607
43. Battaini F (2001) Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol Res 44: 353-361. PMID: 11712865
44. Friedman E, Hoau Yan W, Levinson D, Connell TA, Singh H (1993) Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 33: 520-525. PMID: 8513036
45. Wang HY, Friedman E (1996) Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 40: 568-575. PMID: 8886289
46. Manji HK, Lenox RH (1999) Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46: 1328-1351. PMID: 10578449
47. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, et al. (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281: 2042-2045. PMID: 9748166
48. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, et al. (2006) Phosphatidylinositol 3-kinase gamma signaling through protein kinase Czeta induces NADPH oxidase-mediated oxidant generation and NFkappaB activation in endothelial cells. J Biol Chem 281: 16128-16138. PMID: 16527821
49. Goode N, Hughes K, Woodgett JR, Parker PJ (1992) Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 267: 16878-16882. PMID: 1324914
50. Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32: 577-595. PMID: 16944320
51. Miller JS, Tallarida RJ, Unterwald EM (2009) Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology 56: 1116-1123. doi: 10.1016/j.neuropharm.2009.03.006 PMID: 19328817
52. Miller JS, Tallarida RJ, Unterwald EM (2010) Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice. Brain Res Bull 82: 184-187. doi: 10.1016/j.brainresbull.2010.03.005 PMID: 20347018
53. Gould TD, Einat H, Bhat R, Manji HK (2004) AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swimtest. Int J Neuropsychopharmacol 7: 387-390. PMID: 15315719
54. Rosa AO, Kaster MP, Binfare RW, Morales S, Martin-Aparicio E, et al. (2008) Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry 32: 1549-1556. doi: 10.1016/j.pnpbp.2008.05.020 PMID: 18579278
55. Budni J, Lobato KR, Binfare RW, Freitas AE, Costa AP, et al. (2012) Involvement of PI3K, GSK-3beta and PPARgamma in the antidepressant-like effect of folic acid in the forced swimming test in mice. J Psychopharmacol 26: 714-723. doi: 10.1177/0269881111424456 PMID: 22037925
56. Pan JQ, Lewis MC, Ketterman JK, Clore EL, Riley M, et al. (2011) AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36: 1397-1411. doi: 10.1038/npp.2011.24 PMID: 21389981
57. Baek JH, Cerda O, Trimmer JS (2011) Mass spectrometry-based phosphoproteomics reveals multisite phosphorylation on mammalian brain voltage-gated sodium and potassium channels. Semin Cell Dev Biol 22: 153-159. doi: 10.1016/j.semcdb.2010.09.009 PMID: 20932926
58. Farghaian H, Chen Y, Fu AW, Fu AK, Ip JP, et al. (2011) Scapinin-induced inhibition of axon elongation is attenuated by phosphorylation and translocation to the cytoplasm. J Biol Chem 286: 19724-19734. doi: 10.1074/jbc.M110.205781 PMID: 21487013
59. Wisdom R, Johnson RS, Moore C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. Embo j 18: 188-197. PMID: 9878062
60. Zhang JY, Tao S, Kimmel R, Khavari PA (2005) CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control. J Cell Biol 168: 561-566. PMID: 15699216
61. Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, et al. (2006) NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol 26: 2936-2946. PMID: 16581769
62. König HG, Fenner BJ, Byrne JC, Schwamborn RF, Bernas T, et al. (2012) Fibroblast growth factor homologous factor 1 interacts with NEMO to regulate NF-κB signaling in neurons. J Cell Sci 125: 6058-6070. doi: 10.1242/jcs.111880 PMID: 23097049
63. Schultz C, Konig HG, Del Turco D, Politi C, Eckert GP, et al. (2006) Coincident enrichment of phosphorylated IkappaBalpha, activated IKK, and phosphorylated p65 in the axon initial segment of neurons. Mol Cell Neurosci 33: 68-80. PMID: 16875840
64. Verpelli C, Piccoli G, Zibetti C, Zanchi A, Gardoni F, et al. (2010) Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. J Neurosci. United States. pp. 5830-5842.
65. Gildish I, Manor D, David O, Sharma V, Williams D, et al. (2012) Impaired associative taste learning and abnormal brain activation in kinase-defective eEF2K mice. Learn Mem. United States: 2012 Cold Spring Harbor Laboratory Press. pp. 116-125. doi: 10.1101/lm.023937.111 PMID: 22366775
66. Karyo R, Eskira Y, Pinhasov A, Belmaker R, Agam G, et al. (2010) Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3. Mol Cell Neurosci 45: 449-455. doi: 10.1016/j.mcn.2010.08.004 PMID: 20708687
67. Bain J, McLauchlan H, Elliott M, Cohen P (2003) The specificities of protein kinase inhibitors: an update. Biochem J 371: 199-204. PMID: 12534346
68. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, et al. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315. PMID: 17850214
69. Zhang H, Nagasawa M, Yamada S, Mogami H, Suzuki Y, et al. (2004) Bimodal role of conventional protein kinase C in insulin secretion from rat pancreatic beta cells. J Physiol 561: 133-147. PMID: 15388777
70. Nakamura Y, Ishiura Y, Yokoyama O, Namiki M, De Groat WC (2003) Role of protein kinase C in central muscarinic inhibitory mechanisms regulating voiding in rats. Neuroscience 116: 477-484. PMID: 12559102
71. Bandyopadhyay RS, Faller DV (1997) Regulation of c-jun gene expression in endothelial cells by the protein kinase inhibitor staurosporine. Endothelium 5: 95-105. PMID: 9237043
72. Kamb A, Wee S, Lengauer C (2007) Why is cancer drug discovery so difficult? Nat Rev Drug Discov 6: 115-120. PMID: 17159925
73. Insel TR (2014) The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry. Am J Psychiatry 171: 395-397. doi: 10.1176/appi.ajp.2014.14020138 PMID: 24687194
74. Insel TR, Voon V, Nye JS, Brown VJ, Altevogt BM, et al. (2013) Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev 37: 2438-2444. doi: 10.1016/j.neubiorev.2013. 03.022 PMID: 23563062
75. Insel TR (2012) Next-generation treatments for mental disorders. Sci Transl Med 4: 155ps119. doi: 10.1126/scitranslmed.3004873 PMID: 23052292